221 related articles for article (PubMed ID: 34604097)
1. Advanced Nano-Carriers for Anti-Tumor Drug Loading.
Xiang J; Zhao R; Wang B; Sun X; Guo X; Tan S; Liu W
Front Oncol; 2021; 11():758143. PubMed ID: 34604097
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
[TBL] [Abstract][Full Text] [Related]
4. Synergic Antitumor Effect of Photodynamic Therapy and Chemotherapy Mediated by Nano Drug Delivery Systems.
Aghajanzadeh M; Zamani M; Rajabi Kouchi F; Eixenberger J; Shirini D; Estrada D; Shirini F
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214054
[TBL] [Abstract][Full Text] [Related]
5. Nano-carriers for the Treatment of Tuberculosis.
Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Efficacy and Performance of a New Nano-Drug Carrier in the Treatment of Recurrent Oral Ulcerper.
He Y; Xu Z; Qiu Z; Zheng D; Xie L
J Nanosci Nanotechnol; 2021 Feb; 21(2):1107-1117. PubMed ID: 33183450
[TBL] [Abstract][Full Text] [Related]
7. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
8. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy.
Lu C; Li X; Xia W; Lu S; Luo H; Ye D; Zhang Y; Liu D
Acta Biomater; 2017 Feb; 49():434-443. PubMed ID: 27867110
[TBL] [Abstract][Full Text] [Related]
9. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
Nabi B; Rehman S; Baboota S; Ali J
AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: The Application of Nanodrug Delivery System with Sequential Drug Release Strategies in Cancer Therapy.
Li J; Cao Y; Zhang X; An M; Liu Y
Curr Drug Deliv; 2023 Jul; ():. PubMed ID: 37448370
[TBL] [Abstract][Full Text] [Related]
11. The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy.
Zhao MX; Zhu BJ
Nanoscale Res Lett; 2016 Dec; 11(1):207. PubMed ID: 27090658
[TBL] [Abstract][Full Text] [Related]
12. Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.
De Angelis F; Pujia A; Falcone C; Iaccino E; Palmieri C; Liberale C; Mecarini F; Candeloro P; Luberto L; de Laurentiis A; Das G; Scala G; Di Fabrizio E
Nanoscale; 2010 Oct; 2(10):2230-6. PubMed ID: 20835434
[TBL] [Abstract][Full Text] [Related]
13. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.
Choi WI; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G
J Control Release; 2012 Sep; 162(2):267-75. PubMed ID: 22824783
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Evaluation of Multifunctional Autofluorescent Magnetic Nanoparticle-Based Drug Delivery Systems Against Mammary Cancer.
Li Z; Zhang J; Li X; Guo X; Zhang Z
J Pharm Sci; 2018 Oct; 107(10):2694-2701. PubMed ID: 29935296
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs.
Sun Z; Duan R; Xing D; Pang X; Li Z; Chen X
Curr Cancer Drug Targets; 2017; 17(5):445-455. PubMed ID: 28067177
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
Gao M; Deng H; Zhang W
Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
[TBL] [Abstract][Full Text] [Related]
17. Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology.
Choudhury H; Pandey M; Yin TH; Kaur T; Jia GW; Tan SQL; Weijie H; Yang EKS; Keat CG; Bhattamishra SK; Kesharwani P; Md S; Molugulu N; Pichika MR; Gorain B
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():596-613. PubMed ID: 31029353
[TBL] [Abstract][Full Text] [Related]
18. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.
Moradi Kashkooli F; Soltani M; Souri M
J Control Release; 2020 Nov; 327():316-349. PubMed ID: 32800878
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery.
Alsehli M
Saudi Pharm J; 2020 Mar; 28(3):255-265. PubMed ID: 32194326
[TBL] [Abstract][Full Text] [Related]
20. Construction of a biodegradable, versatile nanocarrier for optional combination cancer therapy.
Wen J; Lv Y; Xu Y; Zhang P; Li H; Chen X; Li X; Zhang L; Liu F; Zeng W; Sun S
Acta Biomater; 2019 Jan; 83():359-371. PubMed ID: 30414486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
